METHODS FOR PURIFYING ENDODERM AND PANCREATIC ENDODERM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS

This invention relates to methods for the enrichment of pancreatic progenitor cells from cell populations derived from pluripotent stem cells, induced pluripotent stem cells and embryonic stem cells.Disclosed herein are the markers CD51 and CD177 for the enrichment of pancreatic progenitors and CD27...

Full description

Saved in:
Bibliographic Details
Main Authors KNOBEL SEBASTIAN MATHIAS, LICKERT HEIKO, MAHADALKAR PALLAVI
Format Patent
LanguageChinese
English
Published 01.05.2020
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:This invention relates to methods for the enrichment of pancreatic progenitor cells from cell populations derived from pluripotent stem cells, induced pluripotent stem cells and embryonic stem cells.Disclosed herein are the markers CD51 and CD177 for the enrichment of pancreatic progenitors and CD275 for the enrichment or depletion of liver progenitors. 本发明涉及从源自多能干细胞、诱导多能干细胞和胚胎干细胞的细胞群中富集胰腺祖细胞的方法。本文公开了用于富集胰腺祖细胞的标志物CD51和CD177，以及用于富集或耗竭肝脏祖细胞的标志物CD275。
Bibliography:Application Number: CN201880038434